These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2431765)

  • 21. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p63 as a complimentary basal cell specific marker to high molecular weight-cytokeratin in distinguishing prostatic carcinoma from benign prostatic lesions.
    Shiran MS; Tan GC; Sabariah AR; Rampal L; Phang KS
    Med J Malaysia; 2007 Mar; 62(1):36-9. PubMed ID: 17682568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations.
    Shah RB; Kunju LP; Shen R; LeBlanc M; Zhou M; Rubin MA
    Am J Clin Pathol; 2004 Oct; 122(4):517-23. PubMed ID: 15487448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples.
    Festuccia C; Angelucci A; Gravina GL; Muzi P; Miano R; Vicentini C; Bologna M
    Int J Oncol; 2005 May; 26(5):1353-62. PubMed ID: 15809728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterization of human prostate carcinoma cell lines.
    van Bokhoven A; Varella-Garcia M; Korch C; Johannes WU; Smith EE; Miller HL; Nordeen SK; Miller GJ; Lucia MS
    Prostate; 2003 Nov; 57(3):205-25. PubMed ID: 14518029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density, and epithelial cell proliferation.
    Vartanian RK; Weidner N
    Lab Invest; 1995 Dec; 73(6):844-50. PubMed ID: 8558846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines.
    Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
    J Cell Physiol; 2000 Jul; 184(1):70-9. PubMed ID: 10825235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of luminal and basal cytokeratins in human breast carcinoma.
    Abd El-Rehim DM; Pinder SE; Paish CE; Bell J; Blamey RW; Robertson JF; Nicholson RI; Ellis IO
    J Pathol; 2004 Jun; 203(2):661-71. PubMed ID: 15141381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype.
    Garcia FU; Haber MM; Chen X
    Prostate; 2007 Nov; 67(15):1686-92. PubMed ID: 17879949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation and stromal-induced growth promotion of murine prostatic tumors.
    Salm SN; Takao T; Tsujimura A; Coetzee S; Moscatelli D; Wilson EL
    Prostate; 2002 May; 51(3):175-88. PubMed ID: 11967952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical investigation of different cytokeratins and vimentin in the prostate from the fetal period up to adulthood and in prostate carcinoma.
    Wernert N; Seitz G; Achtstätter T
    Pathol Res Pract; 1987 Oct; 182(5):617-26. PubMed ID: 2446293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of keratin protein in normal prostate and prostatic tumors. An immunohistochemical study.
    Kuwahara T; Nagayama T
    Acta Pathol Jpn; 1987 Feb; 37(2):339-42. PubMed ID: 2440232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of specific cytokeratin polypeptides in the basal and luminal epithelia of the human prostate.
    Sherwood ER; Theyer G; Steiner G; Berg LA; Kozlowski JM; Lee C
    Prostate; 1991; 18(4):303-14. PubMed ID: 1711687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma.
    Hedrick L; Epstein JI
    Am J Surg Pathol; 1989 May; 13(5):389-96. PubMed ID: 2469333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of high-molecular-weight cytokeratin antigenicity in prostate tissue obtained by transurethral resections.
    Multhaupt HA; Fessler JN; Warhol MJ
    Arch Pathol Lab Med; 2000 Dec; 124(12):1764-7. PubMed ID: 11100054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of basal and luminal epithelium-specific keratins in normal, benign, and malignant breast tissue.
    Dairkee SH; Puett L; Hackett AJ
    J Natl Cancer Inst; 1988 Jul; 80(9):691-5. PubMed ID: 2453676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immunohistologic characterization of human prostatic atypical hyperplasia.
    Chou P; Ray V; Shaw M; Rubenstein M; Guinan P
    Urol Res; 1990; 18(3):193-6. PubMed ID: 1697711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vimentin and cytokeratin expression in nodular hyperplasia and carcinoma of the prostate.
    Heatley M; Maxwell P; Whiteside C; Toner P
    J Clin Pathol; 1995 Nov; 48(11):1031-4. PubMed ID: 8543626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing cytokeratin expression patterns in diethylstilbestrol dipropionate-induced metaplastic lesions of the goat prostate.
    Weijman J; Ramaekers FC; Elsinghorst TA; van Wichen PJ; Zwart P
    Vet Q; 1992 Jan; 14(1):2-7. PubMed ID: 1374200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.